Responsiveness to pembrolizumab in severe early-onset natalizumab associated PML-IRIS in patient with relapsing-remitting multiple sclerosis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Multiple sclerosis 2024-05, Vol.30 (6), p.760-762
Hauptverfasser:	Ercan, Merve Bahar, Kocer, Belgin, Altiparmak, Taylan, Arslan, Ilker
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Female Humans Immune Reconstitution Inflammatory Syndrome - chemically induced Immunologic Factors - adverse effects Leukoencephalopathy, Progressive Multifocal - chemically induced Multiple sclerosis Multiple Sclerosis, Relapsing-Remitting - drug therapy Natalizumab - adverse effects Pembrolizumab
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!